SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
HealthStream, Inc. (HSTM) trades at a trailing P/E of 32.4, forward P/E of 27.8. Trailing earnings yield is 3.09%, forward earnings yield 3.60%. PEG 1.39. Graham Number is $12.90.
Criteria proven by this page:
- VALUE (49/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 27.8 (down from trailing 32.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.39 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 3.09% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 3.60% as earnings recover.
- Analyst consensus target $25.00 (+22.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 61/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
49/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HSTM
Valuation Multiples
P/E (TTM)32.4
Forward P/E27.8
PEG Ratio1.39
Forward PEG1.39
P/B Ratio1.68
P/S Ratio1.96
EV/EBITDA8.8
Per Share Data
EPS (TTM)$0.62
Forward EPS (Est.)$0.73
Book Value / Share$11.95
Revenue / Share$10.27
FCF / Share$2.01
Yields & Fair Value
Earnings Yield3.09%
Forward Earnings Yield3.60%
Dividend Yield0.64%
Graham Number$12.90
SharesGrow IV$27.04 (+32.9%)
Analyst Target$25.00 (+22.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
211.6 |
-3.61 |
2.78 |
3.52 |
- |
| 2017 |
73.8 |
0.47 |
2.46 |
2.98 |
- |
| 2018 |
24.2 |
0.11 |
2.44 |
3.36 |
4.15% |
| 2019 |
55.8 |
-1.00 |
2.60 |
3.47 |
0.01% |
| 2020 |
49.5 |
0.00 |
2.09 |
2.85 |
0.01% |
| 2021 |
142.2 |
-2.50 |
2.45 |
3.24 |
0.00% |
| 2022 |
63.0 |
0.60 |
2.28 |
2.85 |
- |
| 2023 |
54.3 |
1.93 |
2.43 |
2.96 |
0.37% |
| 2024 |
48.3 |
1.51 |
2.69 |
3.31 |
0.35% |
| 2025 |
37.8 |
-4.98 |
1.96 |
2.28 |
0.54% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.12 |
$225.97M |
$3.76M |
1.7% |
| 2017 |
$0.31 |
$247.66M |
$10M |
4% |
| 2018 |
$1.00 |
$231.62M |
$32.22M |
13.9% |
| 2019 |
$0.44 |
$254.11M |
$15.77M |
6.2% |
| 2020 |
$0.44 |
$244.83M |
$14.09M |
5.8% |
| 2021 |
$0.18 |
$256.71M |
$5.85M |
2.3% |
| 2022 |
$0.39 |
$266.83M |
$12.09M |
4.5% |
| 2023 |
$0.50 |
$279.06M |
$15.21M |
5.5% |
| 2024 |
$0.66 |
$291.65M |
$20.01M |
6.9% |
| 2025 |
$0.61 |
$304.06M |
$18.34M |
6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.73 |
$0.72 – $0.74 |
$326.28M |
$325.22M – $327.34M |
3 |
| 2027 |
$0.82 |
$0.81 – $0.83 |
$342.98M |
$341.38M – $344.58M |
3 |
| 2028 |
$0.00 |
$0.00 – $0.00 |
$361.17M |
$359.08M – $363.29M |
1 |
